Published in Pain Med on February 07, 2008
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
Usability testing of a Smartphone for accessing a web-based e-diary for self-monitoring of pain and symptoms in sickle cell disease. J Pediatr Hematol Oncol (2012) 0.97
Adolescent pediatric pain tool for multidimensional measurement of pain in children and adolescents. Pain Manag Nurs (2013) 0.87
Development and validation of a virtual human vignette to compare nurses' assessment and intervention choices for pain in critically ill children. Simul Healthc (2015) 0.80
Health-related quality of life in children with sickle cell disease using the child health questionnaire. J Pediatr Health Care (2012) 0.79
PICU Nurses' Pain Assessments and Intervention Choices for Virtual Human and Written Vignettes. J Pediatr Nurs (2015) 0.79
Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes. Am J Hematol (2012) 0.77
Benchmarking pain outcomes for children with sickle cell disease hospitalized in a tertiary referral pediatric hospital. Pain Res Manag (2012) 0.75
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer (2008) 1.62
Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr (2004) 1.52
Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. Am J Hematol (2013) 1.49
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood (2005) 1.37
Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer (2009) 1.28
Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital. Pediatr Blood Cancer (2008) 1.07
A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality. Pediatr Blood Cancer (2008) 1.04
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood (2012) 0.98
The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood (2013) 0.98
High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer (2011) 0.95
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol (2008) 0.88
Analgesic Response to Morphine in Children with Sickle Cell Disease: A Pilot Study. J Pain Manag (2008) 0.87
Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging (2010) 0.87
The medical home experience among children with sickle cell disease. Pediatr Blood Cancer (2012) 0.86
Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol (2005) 0.85
Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity. Pediatr Blood Cancer (2011) 0.84
Oral iron chelation and the treatment of iron overload in a pediatric hematology center. Pediatr Blood Cancer (2009) 0.81
Thromboelastographic and hemostatic characteristics in pediatric patients with sickle cell disease. Arch Pathol Lab Med (2005) 0.81
Shorter hospitalization trends among children with sickle cell disease. Pediatr Blood Cancer (2012) 0.80
Effects of Patient Controlled Analgesia Hydromorphone during Acute Painful Episodes in Adolescents with Sickle Cell Disease: A Pilot Study. J Pain Manag (2008) 0.80
Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities. Am J Hematol (2012) 0.80
Respiratory symptoms and acute painful episodes in sickle cell disease. J Pediatr Oncol Nurs (2009) 0.79
Association of care in a medical home and health care utilization among children with sickle cell disease. J Natl Med Assoc (2013) 0.79
Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatr Blood Cancer (2011) 0.79
Trends in blood transfusion among hospitalized children with sickle cell disease. Pediatr Blood Cancer (2013) 0.78
Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications. Am J Hematol (2009) 0.77
Integration of Administrative Data and Chart Review for Reporting Health Care Utilization Among Children With Sickle Cell Disease. Sage Open (2013) 0.76
The ASH Choosing Wisely®campaign: five hematologic tests and treatments to question. Hematology Am Soc Hematol Educ Program (2013) 0.76
Parental information, motivation, and adherence behaviors among children with sickle cell disease. Pediatr Blood Cancer (2013) 0.75
Long-term use of hydroxyurea for sickle cell anemia. JAMA (2003) 0.75
Creating a Pediatric Joint Council to Promote Patient Safety and Quality, Governance, and Accountability Across Johns Hopkins Medicine. Jt Comm J Qual Patient Saf (2017) 0.75
The second century of sickle cell disease. Pediatr Blood Cancer (2012) 0.75